Empiric Antibiotic Therapy for Sternal Dehiscence with Fever and Leukocytosis Post-CABG
Initiate vancomycin plus an anti-pseudomonal beta-lactam (piperacillin-tazobactam, cefepime, or a carbapenem) immediately for suspected deep sternal wound infection following CABG in a patient presenting with fever and leukocytosis.
Immediate Empiric Regimen
Recommended First-Line Combination
Vancomycin 15–20 mg/kg IV every 8–12 hours to cover methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci, which account for the majority of sternal wound infections post-cardiac surgery 1, 2, 3.
Plus one of the following anti-pseudomonal agents:
Rationale for Dual Coverage
Staphylococci—particularly methicillin-resistant strains—cause 55–93% of deep sternal wound infections, with coagulase-negative staphylococci responsible for approximately half of cases 5, 2, 3.
Gram-negative bacilli, especially Pseudomonas aeruginosa, account for 25–55% of pathogens in deep sternal wound infections and carry high mortality when inadequately treated 3.
Vancomycin alone is inadequate because it lacks activity against gram-negative organisms, which are common in post-CABG sternal infections 1, 3.
A first- or second-generation cephalosporin is recommended only for prophylaxis in patients without MRSA colonization, not for treatment of established infection 1.
Diagnostic Workup (Obtain Before or Immediately After Starting Antibiotics)
Obtain at least two sets of blood cultures from separate peripheral sites; bacteremia is the first manifestation of sternal wound infection in many cases, often preceding local wound signs 5.
Perform sternal wound aspiration or deep tissue culture if no other source of infection is identified, as blood cultures may be negative despite deep infection 5.
Order complete blood count, comprehensive metabolic panel, and inflammatory markers (CRP, procalcitonin if available) to assess severity and guide duration of therapy 1.
Obtain chest radiograph or CT to evaluate for mediastinitis, fluid collections, or sternal dehiscence 1.
Clinical Context and Risk Factors
Fever with leukocytosis in a post-CABG patient with sternal dehiscence is deep sternal wound infection until proven otherwise, even when local wound signs are absent 5, 6.
Independent risk factors for deep sternal wound infection include reoperation for bleeding, prolonged operative time, postoperative low cardiac output, and use of internal mammary artery grafts 2, 6.
Antibiotic resistance is a critical concern: P. aeruginosa isolates show 100% resistance to cefazolin and cefuroxime, while staphylococci demonstrate 100% resistance to penicillin-G and >70% resistance to clindamycin 3.
No isolates are resistant to vancomycin, linezolid, or tigecycline in recent surveillance data 3.
Reassessment at 48–72 Hours
Review culture and susceptibility results and narrow therapy to the most appropriate agent based on identified pathogens 1.
If cultures grow MRSA or methicillin-resistant coagulase-negative staphylococci, continue vancomycin and discontinue the beta-lactam if no gram-negative organisms are isolated 1.
If cultures grow P. aeruginosa, continue the anti-pseudomonal beta-lactam and consider adding an aminoglycoside (gentamicin or amikacin) for synergy, as combination therapy raises clinical improvement rates to ~85% versus ~50% with monotherapy 4.
If cultures are negative at 48 hours and the patient is clinically stable, consider de-escalating vancomycin but maintain gram-negative coverage until an alternative diagnosis is confirmed 1, 4.
Surgical Management
Deep sternal wound infection requires aggressive surgical debridement in the absence of complicating circumstances; primary or secondary closure with muscle or omental flap is recommended 1.
Vacuum-assisted closure therapy in conjunction with early and aggressive debridement is an effective adjunctive therapy 1.
Catheter irrigation should be reserved for patients without infection or those with infection but without internal mammary artery grafts in whom dehiscence occurs <1 month after sternotomy; all others should have closure with muscle flaps 6.
Muscle flap closure is the primary treatment if the sternum cannot be restabilized or as secondary treatment if catheter irrigation fails 6.
Duration of Antibiotic Therapy
Continue antibiotics until further debridement is no longer necessary, the patient has improved clinically, and fever has been resolved for 48–72 hours 1.
Procalcitonin monitoring may be useful to guide antimicrobial discontinuation, as a PCT ratio >1.14 (day 1 to day 2 postoperatively) indicates successful surgical eradication of the infectious focus 1.
For documented bacteremia, a minimum of 7–10 days of therapy is recommended, with longer courses (up to 4–6 weeks) for osteomyelitis or mediastinitis 1.
Critical Pitfalls to Avoid
Do not delay antibiotics while awaiting culture results; each hour of delay increases mortality from gram-negative bacteremia 7, 4.
Do not use a first- or second-generation cephalosporin alone for treatment of established sternal wound infection, as these agents lack adequate coverage for P. aeruginosa and MRSA 1, 4, 3.
Do not omit vancomycin from the initial regimen in post-CABG patients with fever and sternal dehiscence, given the high prevalence of methicillin-resistant staphylococci 1, 2, 3.
Do not attribute persistent fever to antibiotic failure before 48–72 hours; reassess with repeat cultures, imaging, and consideration of surgical source control 1.
Do not overlook the need for early surgical consultation, as medical therapy alone is insufficient for deep sternal wound infection 1, 6.